EDGAR Filing Documents for 0001437749-17-011532

Form 8-K - Current report:

SEC Accession No. 0001437749-17-011532

Filing Date

2017-06-20

Accepted

2017-06-20 16:15:21

Documents

Period of Report

2017-06-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	acrx20170619_8k.htm	8-K	43849
2	EXHIBIT 10.1	ex10-1.htm	EX-10.1	79894
	Complete submission text file	0001437749-17-011532.txt		125043

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063

Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500

ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)